Brochure | August 10, 2022

Analytical Development & Characterization For AAV

Due to its ability to express a given transgene at therapeutic levels and potential as a cure for chronic genetic diseases, Adeno-associated viruses (AAVs) have become one of the most commonly used gene therapy vectors.

AAV gene therapies and any precursor starting materials must be well-characterized to understand the relationship between product quality attributes, manufacturing processes, patient safety and efficacy. Read this flyer to learn more about our assay packages.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development